Postmenopausal Osteoporosis

Our ultimate goal is to make donor-candidate education and acceptance more empiric and defensible.Our study provides a framework for donor evaluation that is centered on the simultaneous consideration of many clinical factors relevant to the risk of end-stage renal disease, but its application requires insight and sensitivity to nuance on the part of the clinician.Suggested framing is described in detail in the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines for clinical practice. 5 We see our work as a starting point and advocate strongly for continued efforts to improve the precision and generalizability of estimates of risk before and after donation.